RU2011138963A - Метаболиты, являющиеся церамидными аналогами - Google Patents

Метаболиты, являющиеся церамидными аналогами Download PDF

Info

Publication number
RU2011138963A
RU2011138963A RU2011138963/15A RU2011138963A RU2011138963A RU 2011138963 A RU2011138963 A RU 2011138963A RU 2011138963/15 A RU2011138963/15 A RU 2011138963/15A RU 2011138963 A RU2011138963 A RU 2011138963A RU 2011138963 A RU2011138963 A RU 2011138963A
Authority
RU
Russia
Prior art keywords
compound
iii
alkyl chain
pharmaceutical composition
formula
Prior art date
Application number
RU2011138963/15A
Other languages
English (en)
Russian (ru)
Inventor
Фолькер БРИНКМАНН
Гуидо ЙОРДИНЕ
Маркус ЦОЛЛИНГЕР
Клаудиа ЗАЙЕР
Original Assignee
Новартис Аг
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Новартис Аг filed Critical Новартис Аг
Publication of RU2011138963A publication Critical patent/RU2011138963A/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C07C233/17—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/18—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Transplantation (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
RU2011138963/15A 2009-02-24 2010-02-23 Метаболиты, являющиеся церамидными аналогами RU2011138963A (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP09153550.0 2009-02-24
EP09153550 2009-02-24
PCT/EP2010/052231 WO2010097371A1 (en) 2009-02-24 2010-02-23 Ceramide-analogous metabolites

Publications (1)

Publication Number Publication Date
RU2011138963A true RU2011138963A (ru) 2013-04-10

Family

ID=40447014

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2011138963/15A RU2011138963A (ru) 2009-02-24 2010-02-23 Метаболиты, являющиеся церамидными аналогами

Country Status (14)

Country Link
US (1) US8673982B2 (cg-RX-API-DMAC7.html)
EP (1) EP2400960B1 (cg-RX-API-DMAC7.html)
JP (1) JP2012518671A (cg-RX-API-DMAC7.html)
KR (1) KR20110126631A (cg-RX-API-DMAC7.html)
CN (1) CN102333530A (cg-RX-API-DMAC7.html)
AU (1) AU2010217605B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI1007994A2 (cg-RX-API-DMAC7.html)
CA (1) CA2752003A1 (cg-RX-API-DMAC7.html)
ES (1) ES2411138T3 (cg-RX-API-DMAC7.html)
MX (1) MX2011008876A (cg-RX-API-DMAC7.html)
PL (1) PL2400960T3 (cg-RX-API-DMAC7.html)
PT (1) PT2400960E (cg-RX-API-DMAC7.html)
RU (1) RU2011138963A (cg-RX-API-DMAC7.html)
WO (1) WO2010097371A1 (cg-RX-API-DMAC7.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2663833C2 (ru) * 2013-03-05 2018-08-10 Биокон Лимитед Способ получения соединений 2-амино-1,3-пропандиола и их солей

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2888634C (en) * 2012-10-19 2019-10-08 Ruth Perez Compositions and methods for the treatment of parkinson's disease
HK1212324A1 (en) * 2012-11-30 2016-06-10 株式会社爱茉莉太平洋 Novel pseudoceramide compound and production method for same
KR101510683B1 (ko) 2013-09-03 2015-04-10 (주)네오팜 카나비노이드 수용체에 길항작용을 가지는 신규한 유사 세라마이드 유도체 및 이를 포함하는 약학 또는 화장품 조성물
EP3118621A1 (en) 2015-07-14 2017-01-18 Fundació Institut d'Investigació Biomèdica de Bellvitge (IDIBELL) Methods and compositions for the diagnosis and for the treatment of adrenoleukodystrophy

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR0155015B1 (ko) * 1992-10-21 1998-12-01 고우야 마사시 2-아미노-1,3-프로판디올 화합물 및 면역 억제제
US5948820A (en) * 1994-08-22 1999-09-07 Yoshitomi Pharmaceutical Industries, Ltd. Benzene compound and pharmaceutical use thereof
DE69524962T4 (de) * 1994-08-22 2003-08-28 Mitsubishi Pharma Corp., Osaka Benzolderivate und deren medizinische verwendung
PL1773307T3 (pl) * 2004-07-30 2015-03-31 Novartis Ag Preparaty 2-amino-1,3-propanodioli i ich analogów
GT200600350A (es) * 2005-08-09 2007-03-28 Formulaciones líquidas
RU2433117C2 (ru) * 2005-12-15 2011-11-10 Мицубиси Танабе Фарма Корпорейшн Аминное соединение и его применение в медицинских целях
CN101240002B (zh) * 2007-02-07 2011-01-26 首都医科大学 脂肪酰氨基酰阿糖胞苷缀合物、其制备方法和应用

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2663833C2 (ru) * 2013-03-05 2018-08-10 Биокон Лимитед Способ получения соединений 2-амино-1,3-пропандиола и их солей

Also Published As

Publication number Publication date
US20110306672A1 (en) 2011-12-15
ES2411138T3 (es) 2013-07-04
MX2011008876A (es) 2011-09-21
EP2400960B1 (en) 2013-04-17
PL2400960T3 (pl) 2013-08-30
EP2400960A1 (en) 2012-01-04
AU2010217605B2 (en) 2012-07-26
KR20110126631A (ko) 2011-11-23
AU2010217605A1 (en) 2011-08-18
PT2400960E (pt) 2013-06-28
JP2012518671A (ja) 2012-08-16
WO2010097371A1 (en) 2010-09-02
US8673982B2 (en) 2014-03-18
BRPI1007994A2 (pt) 2018-03-13
CN102333530A (zh) 2012-01-25
CA2752003A1 (en) 2010-09-02

Similar Documents

Publication Publication Date Title
RU2013111077A (ru) Дипептидное пролекарство, его применение и лекарственное средство
UA110013C2 (uk) Застосування композиції для лікування шарко-марі-тута і пов'язаних з нею розладів
CA2777746A1 (en) Benzoimidazole compounds and uses thereof
RU2010144637A (ru) Замещенные гамма-лактамы в качестве терапевтических агентов
MA33076B1 (fr) Utilisation d'un inhibiteur de la gamma-secretase pour le traitement du cancer
EA200970173A1 (ru) Химические соединения
EA201001595A1 (ru) Соединения и композиции в качестве модуляторов активности gpr119
RU2009141187A (ru) Серосодержащие соединения как ингибиторы ns3 серинпротеазы вируса гепатита с
BR112014003981A2 (pt) compostos de pirimido-piridazinona e seu uso
JP2012525393A5 (cg-RX-API-DMAC7.html)
RU2015114797A (ru) Композиции для ухода за полостью рта
AR077138A1 (es) Composiciones farmaceuticas utiles para tratar el vhc
RU2011153353A (ru) Кетолидные соединения, обладающие противомикробной активностью
RU2015122032A (ru) Оксазолидинонсодержащие соединения, композиции и способы их использования
EP3661496A1 (en) Treatment of staphylococcal and enterococcal infections using substituted nitrostyrene compounds
JP2013502461A5 (cg-RX-API-DMAC7.html)
RU2012150501A (ru) Противораковые стероидные лактоны, ненасыщенные в положении 7(8)
RU2009128970A (ru) Производные изосорбидмононитрата для лечения кишечных заболеваний
RU2009111387A (ru) Фармацевтические композиции для лечения грибковых инфекций
CR20220227A (es) Derivados de 1,2,4-oxadiazol como agonistas del receptor hepático x
RU2008137723A (ru) Производные рапамицина для лечения нейробластомы
CA2629364A1 (en) Pharmaceutical formulations and uses thereof in the treatment of female sexual dysfunction
MX2009011818A (es) Formulaciones de aminoacido n-halogenado con compuestos anti-inflamatorios.
RU2014123690A (ru) Терапевтическое средство при артрозе
MX2012004082A (es) Inhibidores de cxcr1/2 como adyuvantes en el trasplante de islotes pancreaticos.

Legal Events

Date Code Title Description
FA92 Acknowledgement of application withdrawn (lack of supplementary materials submitted)

Effective date: 20140718